Deming Tan

2.2k total citations
46 papers, 1.1k citations indexed

About

Deming Tan is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Deming Tan has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 26 papers in Hepatology and 18 papers in Molecular Biology. Recurrent topics in Deming Tan's work include Hepatitis B Virus Studies (30 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (14 papers). Deming Tan is often cited by papers focused on Hepatitis B Virus Studies (30 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (14 papers). Deming Tan collaborates with scholars based in China, United States and Belgium. Deming Tan's co-authors include Xiaoyu Fu, Zhouhua Hou, Xuwen Xu, Shuiping Liu, Jinlin Hou, Jiaji Jiang, Meifang Han, Qin Ning, Yongtao Sun and Ledu Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Deming Tan

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deming Tan China 19 634 533 440 373 112 46 1.1k
Anna Shavinskaya Germany 3 554 0.9× 692 1.3× 327 0.7× 193 0.5× 77 0.7× 3 1.0k
Xiangjun Zhai China 24 609 1.0× 499 0.9× 577 1.3× 423 1.1× 135 1.2× 65 1.4k
Saifeng Wang China 8 274 0.4× 152 0.3× 453 1.0× 439 1.2× 88 0.8× 8 708
Fung‐Yu Huang Hong Kong 16 909 1.4× 823 1.5× 219 0.5× 75 0.2× 80 0.7× 30 1.2k
Xiumei Chi China 18 504 0.8× 512 1.0× 175 0.4× 64 0.2× 213 1.9× 53 917
Magdalena Filipowicz Sinnreich Switzerland 13 723 1.1× 978 1.8× 419 1.0× 287 0.8× 551 4.9× 22 1.6k
K. Koike Japan 4 745 1.2× 442 0.8× 373 0.8× 129 0.3× 99 0.9× 7 1.0k
Magdalena A. Budzinska Australia 10 561 0.9× 477 0.9× 140 0.3× 72 0.2× 47 0.4× 14 729
Naglaa Zayed Egypt 15 444 0.7× 428 0.8× 140 0.3× 101 0.3× 41 0.4× 63 665
Emilie Estrabaud France 11 457 0.7× 437 0.8× 284 0.6× 78 0.2× 136 1.2× 17 877

Countries citing papers authored by Deming Tan

Since Specialization
Citations

This map shows the geographic impact of Deming Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deming Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deming Tan more than expected).

Fields of papers citing papers by Deming Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deming Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deming Tan. The network helps show where Deming Tan may publish in the future.

Co-authorship network of co-authors of Deming Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Deming Tan. A scholar is included among the top collaborators of Deming Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deming Tan. Deming Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fu, Xiaoyu, et al.. (2019). Plasma miR-146a predicts serological conversion of hepatitis B e-antigen (HBeAg) in chronic hepatitis B patients treated with nucleotide analogs. Annals of Translational Medicine. 7(18). 449–449. 4 indexed citations
3.
Wu, Di, Meifang Han, Yong‐Ping Chen, et al.. (2019). Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study. Hepatology International. 13(5). 573–586. 34 indexed citations
4.
Wen, Ya, Shifang Peng, Lei Fu, et al.. (2018). Serum levels of miRNA in patients with hepatitis B virus-associated acute-on-chronic liver failure. Hepatobiliary & pancreatic diseases international. 17(2). 126–132. 22 indexed citations
5.
Shen, Sheng, Xieer Liang, Kamal Hamed, et al.. (2017). Effect of hepatitis B virus subgenotype on antiviral response in nucleoside‐treated hepatitis B envelope antigen‐positive patients. Hepatology Research. 48(2). 134–143. 13 indexed citations
6.
Wu, Daxian, Xiaoyu Fu, Guozhong Gong, et al.. (2017). Novel HBV mutations and their value in predicting efficacy of conventional interferon. Hepatobiliary & pancreatic diseases international. 16(2). 189–196.
7.
Fu, Xiaoyu, Deming Tan, Xiaoguang Dou, Jinjun Chen, & Juan Wu. (2016). A multi-center clinical study comparing Sansure Magb and CAP/CTM HBV tests in the quantitative detection of HBV DNA. The Journal of Infection in Developing Countries. 10(7). 755–761. 4 indexed citations
8.
Wu, Daxian, Xiaoyu Fu, Ya Wen, et al.. (2016). High-resolution melting combines with Bayes discriminant analysis: a novel hepatitis C virus genotyping method. Clinical and Experimental Medicine. 17(3). 325–332. 6 indexed citations
9.
Hou, Jinlin, Guangfeng Shi, Mobin Wan, et al.. (2015). Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B. Advances in Therapy. 32(8). 727–741. 18 indexed citations
10.
Fu, Xiaoyu, Xiaoling Song, Yanyan Li, Deming Tan, & Guozhen Liu. (2015). Hepatitis B virus X protein upregulates DNA methyltransferase 3A/3B and enhances SOCS-1CpG island methylation. Molecular Medicine Reports. 13(1). 301–308. 24 indexed citations
11.
Huang, Xiangbo, Lü Long, Jinjun Chen, et al.. (2015). Traceability, reproducibility and clinical evaluation of Sansure Realtime HCV RNA assay. BMC Infectious Diseases. 16(1). 47–47. 2 indexed citations
12.
13.
Ning, Qin, Meifang Han, Yongtao Sun, et al.. (2014). Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial). Journal of Hepatology. 61(4). 777–784. 174 indexed citations
14.
Chen, Li, et al.. (2013). miR-197 Expression in Peripheral Blood Mononuclear Cells from Hepatitis B Virus-Infected Patients. Gut and Liver. 7(3). 335–342. 34 indexed citations
15.
Zhang, Yinxin, Yuqi Wang, Tao Liu, et al.. (2013). Analysis of hepatitis B virus genotyping and drug resistance gene mutations based on massively parallel sequencing. Journal of Virological Methods. 193(2). 341–347. 10 indexed citations
16.
Fu, Xiaoyu, Deming Tan, Zhouhua Hou, et al.. (2012). MicroRNA expression profiles of LO2 cells expressing the wild-type and mutant HBx gene. Molecular Medicine Reports. 7(2). 633–641. 2 indexed citations
17.
18.
Yao, Guangbi, Chengwei Chen, Hong Ren, et al.. (2008). Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China. Hepatology International. 2(1). 136–136. 39 indexed citations
19.
Tan, Deming, et al.. (2007). Polymorphism Analyses of Hepatitis B Virus X Gene in Hepatocellular Carcinoma Patients from Southern China. Acta Biochimica et Biophysica Sinica. 39(4). 265–272. 14 indexed citations
20.
Yang, Yongfeng, et al.. (2007). Mycophenolate mofetil prevents lethal acute liver failure in mice induced by bacille Calmette‐Guérin and lipopolysaccharide. Journal of Gastroenterology and Hepatology. 23(4). 611–618. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Shavinskaya Breakdown of academic impact, for papers by Xiangjun Zhai Breakdown of academic impact, for papers by Saifeng Wang Breakdown of academic impact, for papers by Fung‐Yu Huang Breakdown of academic impact, for papers by Xiumei Chi Breakdown of academic impact, for papers by Magdalena Filipowicz Sinnreich Breakdown of academic impact, for papers by K. Koike Breakdown of academic impact, for papers by Magdalena A. Budzinska Breakdown of academic impact, for papers by Naglaa Zayed Breakdown of academic impact, for papers by Emilie Estrabaud
Rankless by CCL
2026